The Aperlena Verdict
Open raceNo supplier dominates: 5 different companies have won the last 5 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- -43.5%
Based on 5 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe contract covers a three-year supply of laboratory products for microbial identification and rapid agglutination tests. The procuring entity is located in Italy, and the delivery period spans three years. No lots are mentioned in the notice, so the supply is treated as a single scope covering microbial identification products and rapid agglutination testing materials for laboratory use.
Description
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in Italian.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 17 hours ago
More from this buyer
Full buyer profile3 open tenders right now
- Polymerase chain reaction - Three-year supply, framework agreement, of oligonucleotides, taqman and probes, with optional 12-month extension 20 days left
- Laboratory glassware - Three-year supply of columns, with possible six-month extension and mandatory fifth 27 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Innovative Diagnostics SAS Società per Azioni Semplificata; IDEXX LABORATORIES ITALIA SRL; Gold Standard Diagnostics Trieste S.r.l. a socio unico; R-Biopharm Italia Srl; Merck Life Science S.r.l.; PRODOTTI GIANNI SRL | 1 | €402,468 | Apr 2026 |
| INNOVATIVE DIAGNOSTICS | 1 | €396,667 | Feb 2026 |
| IDEXX LABORATORIES ITALIA SRL; Gold Standard Diagnostics Trieste S.r.l. | 1 | €299,569 | Nov 2025 |
| Innovative Diagnostics SAS Società per Azioni Semplificata | 1 | €175,898 | Apr 2026 |
| QIAGEN S.r.l.; Generon S.p.A.; ALPHA IVD SPA; PRODOTTI GIANNI SRL; Carlo Erba Reagents S.r.l.; VWR INTERNATIONAL SRL; TEMA RICERCA SRL; Roche Diagnostics S.p.A. | 1 | €143,655 | May 2026 |
Based on 5 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 7 comparable contracts this buyer awarded in this sector over the last 4 years.
- Lower quartile
- €237,734
- Median award
- €388,946
- Upper quartile
- €399,568
This tender is estimated 43.7% below that median
Most recent awards
- Reattivi per laboratorio - FORNITURA TRIENNALE DI PRODOTTI INFUNGIBILI LIFE TECHNOLOGIES €1,127,991
- Reattivi per laboratorio - FORNITURA TRIENNALE IN ACCORDO QUADRO DI KIT PER ESTRAZIONE ED AMPLIFICAZIONE €143,655
- Reattivi per laboratorio - procedura aperta in modalità telematica per la fornitura triennale, in accordo quadro, di kit vari per laboratorio, con eventuale proroga semestrale e quinto d’obbligo €402,468
- Reattivi per laboratorio - Fornitura triennale prodotti infungibili Qiagen €388,946
- Reagenti e mezzi di contrasto - 2025_212579189 KIT IBR €175,898
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,435,172
- Buyer track record on Aperlena
- 19 notices tracked · 11 awarded
- €4,417,821 in awarded contracts
Never miss a tender like this
274 new notices in Medical equipment & pharmaceuticals in Italy in the last 7 days. Get an email when new ones appear. Free.
Set up my alert